Ovation Science Stock Investor Sentiment

OVATF Stock  USD 0.01  0.02  64.81%   
Roughly 62% of Ovation Science's investor base is looking to short. The analysis of overall sentiment of trading Ovation Science pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ovation Science's historical and current headlines, can help investors time the market. In addition, many technical investors use Ovation Science stock news signals to limit their universe of possible portfolio assets.
Ovation Science pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ovation daily returns and investor perception about the current price of Ovation Science as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at gurufocus.com         
SXTC Stock Surges with a 6.49 percent Jump Amidst Market Activity
Gurufocus Stories at Macroaxis
few days ago at news.google.com         
Why Interpublic Shares Are Trading Higher By Around 14 Here Are 20 Stocks Moving Premarket - Benzing...
Google News at Macroaxis
over a month ago at zacks.com         
Ovid Therapeutics Reports Q3 Loss, Tops Revenue Estimates
zacks News
over a month ago at globenewswire.com         
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz-Photodynamic Therap...
Macroaxis News: globenewswire.com
over a month ago at news.google.com         
Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc - Yahoo Finance
Google News at Macroaxis
over three weeks ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires New Stake in Biofrontera Inc
Gurufocus Stories at Macroaxis
over three months ago at benzinga.com         
Why FSD Pharma Stock Is Seeing Huge Gains
benzinga news
over three months ago at finance.yahoo.com         
247 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
Yahoo News
over three months ago at news.google.com         
FSD Pharma provides Corporate Update HUGE Stock News - StockTitan
Google News at Macroaxis
over three months ago at investorplace.com         
HUGE Stock Earnings FSD Pharma Misses EPS for Q2 2024
sbwire news
over three months ago at news.google.com         
Lucy Scientific shares to be delisted from Nasdaq By Investing.com - Investing.com India
Google News at Macroaxis
over two weeks ago at simplywall.st         
Lifecore Biomedical, Inc. Soars 36 percent But Its A Story Of Risk Vs Reward
Simply Wall St News at Macroaxis
over three weeks ago at gurufocus.com         
Lifecore Biomedical Hosts Virtual Investor Day
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Yahoo News
over two months ago at insidermonkey.com         
Lifecore Biomedical, Inc. Q1 2025 Earnings Call Transcript
insidermonkey News
3 days ago at kalkinemedia.com         
Rockwells Medium-Voltage Drive Technology Helps West Fraser Reduce Annual Energy Bill
news
few days ago at businesswire.com         
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote FOR Company Nominees Nancy K. Bryan, Thomas ...
businesswire News
over a week ago at investing.com         
Rockwell Automations SVP Tessa Myers sells 74,085 in stock
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Groups Nomin...
Yahoo News
over three weeks ago at news.google.com         
Kamada Q3 2024 Earnings Preview - MSN
Google News at Macroaxis
over a month ago at gurufocus.com         
Kamada Ltd Q3 2024 Earnings Call Highlights Strong Revenue Growth and Increased EBITDA ...
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI , Expanding its ...
Yahoo News
over a month ago at investing.com         
Disposition of 13371 shares by Halstead Michael of Intracellular at 88.17 subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Intra-Cellular Therapies Submits Supplemental New Drug Application to FDA for CAPLYTA for the Treatm...
Yahoo News
over a month ago at simplywall.st         
Revenues Tell The Story For Intra-Cellular Therapies, Inc. As Its Stock Soars 26
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ovation Science that are available to investors today. That information is available publicly through Ovation media outlets and privately through word of mouth or via Ovation internal channels. However, regardless of the origin, that massive amount of Ovation data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ovation Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ovation Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ovation Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ovation Science alpha.

Ovation Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ovation Pink Sheet analysis

When running Ovation Science's price analysis, check to measure Ovation Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovation Science is operating at the current time. Most of Ovation Science's value examination focuses on studying past and present price action to predict the probability of Ovation Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovation Science's price. Additionally, you may evaluate how the addition of Ovation Science to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Transaction History
View history of all your transactions and understand their impact on performance